; Whereas the World Health Organization’s tobacco policy recommendations fail to acknowledge that available science, technology, and innovation can accelerate the decline of cigarette smoking worldwide and reduce smoking-related death and disease; Whereas although the best health outcome for current smokers is to quit nicotine altogether, the reality is that less than 10 percent of adult smokers will successfully quit cigarettes in a given year; Whereas the Food and Drug Administration’s tobacco control policy recognizes this reality and provides global health regulators a pathway forward to move adult smokers down the continuum of risk; Whereas pursuant to the bipartisan Family Smoking Prevention and Tobacco Control Act, the Food and Drug Administration (FDA) follows an inclusive, transparent regulatory framework that promotes innovation in tobacco products based on a rigorous scientific evaluation, including minimizing unintended use of such products by nonsmokers, former smokers, and youth, where only those products determined to be appropriate for the protection of public health receive FDA authorization; Whereas the FDA regularly engages the private sector in an open and transparent manner regarding the development of such innovative products; Whereas the World Health Organization continues to cite an irreconcilable and inherent conflict to prohibit any engagement with or input from the tobacco sector and does not acknowledge the Food and Drug Administration’s review and regulation of science, technology, and innovation that can potentially reduce the harms associated with cigarette smoking; and Whereas policies based on the exclusion of any industry for which they seek to regulate do not advance sound health policy, and are antithetical to fundamental United States values of equal protection, free speech, due process, and the right to petition: Now, therefore, be it